CLN.WAライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (3 5月 2024 @ 00:00):

Stats
本日の出来高	49 759.00
平均出来高	19 089.00
時価総額	792.40M
EPS	PLN-0.130 ( 2023-11-22 )
次の収益日	( PLN0 ) 2024-05-22
Last Dividend	PLN0.0900 ( 2023-06-29 )
Next Dividend	PLN0 ( N/A )
P/E	-28.22
ATR14	PLN0.0350 (0.23%)

ボリューム相関

長: 0.07 (neutral)

短: -0.65 (moderate negative)

Signal:(45.475) Neutral

Celon Pharma S.A. 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Celon Pharma S.A. 相関 - 通貨/商品

-0.61
( weak negative )

-0.78
( moderate negative )

0.00
( neutral )

-0.58
( weak negative )

0.47
( neutral )

0.71
( moderate )

Celon Pharma S.A. 財務諸表

Annual	2023
収益:	PLN164.39M
総利益:	PLN97.58M (59.35 %)
EPS:	PLN-0.550

FY	2023
収益:	PLN164.39M
総利益:	PLN97.58M (59.35 %)
EPS:	PLN-0.550

FY	2022
収益:	PLN161.92M
総利益:	PLN95.45M (58.95 %)
EPS:	PLN-0.770

FY	2021
収益:	PLN169.56M
総利益:	PLN107.84M (63.60 %)
EPS:	PLN-0.111

Financial Reports:

No articles found.

Celon Pharma S.A. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0.0900 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)

Celon Pharma S.A. Dividend Information - No Dividend Player

Dividend Sustainability Score: 1.652 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	PLN0.170	2017-05-31
Last Dividend	PLN0.0900	2023-06-29
Next Dividend	PLN0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	7	--
Total Paid Out	PLN1.110	--
Avg. Dividend % Per Year	0.00%	--
Score	0.73	--
Div. Sustainability Score	1.652
Div.Growth Potential Score	0
Div. Directional Score	0.537	--

Next Divdend (Est)
(2025-04-08)

PLN0.0386 Estimate 3.10 %

Dividend Stability

0.25 Very Poor

Dividend Score

0.73

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for WSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
ASB.WA	Ex Dividend Knight	2023-06-23	Semi-Annually	0.00%
MBR.WA	Ex Dividend Junior	2023-06-30	Annually	0.00%
1AT.WA	Ex Dividend Junior	2023-06-21	Sporadic	0.00%
K2H.WA	Ex Dividend Junior	2023-07-03	Sporadic	0.00%
ERB.WA	Ex Dividend Junior	2023-05-25	Sporadic	0.00%
ULG.WA	Ex Dividend Junior	2023-06-16	Annually	0.00%
CIE.WA	Ex Dividend Junior	2023-06-26	Sporadic	0.00%
PZU.WA	Ex Dividend Junior	2023-09-06	Annually	0.00%
BCS.WA	Ex Dividend Knight	2023-07-06	Annually	0.00%
NTT.WA	Ex Dividend Junior	2023-09-26	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.135	1.500	-2.69	-4.04	[0 - 0.5]
returnOnAssetsTTM	-0.0388	1.200	-1.295	-1.554	[0 - 0.3]
returnOnEquityTTM	-0.0481	1.500	-1.645	-2.47	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.20	0.800	4.01	3.21	[1 - 3]
quickRatioTTM	1.893	0.800	3.57	2.86	[0.8 - 2.5]
cashRatioTTM	0.375	1.500	9.03	10.00	[0.2 - 2]
debtRatioTTM	0.0449	-1.500	9.25	-10.00	[0 - 0.6]
interestCoverageTTM	-8.21	1.000	-4.15	-4.15	[3 - 30]
operatingCashFlowPerShareTTM	-0.162	2.00	-0.0539	-0.108	[0 - 30]
freeCashFlowPerShareTTM	-0.801	2.00	-0.400	-0.801	[0 - 20]
debtEquityRatioTTM	0.0574	-1.500	9.77	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.606	1.000	3.24	3.24	[0.2 - 0.8]
operatingProfitMarginTTM	-0.131	1.000	-4.62	-4.62	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.325	1.000	-2.92	-2.92	[0.2 - 2]
assetTurnoverTTM	0.289	0.800	-1.408	-1.127	[0.5 - 2]
Total Score				1.652

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-36.05	1.000	-3.74	0	[1 - 100]
returnOnEquityTTM	-0.0481	2.50	-1.058	-2.47	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.801	2.00	-0.267	-0.801	[0 - 30]
dividendYielPercentageTTM	0.580	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.162	2.00	-0.0539	-0.108	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0506	1.000	-3.76	0	[0.1 - 0.5]
Total Score				-0.579

Celon Pharma S.A.

Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. is a subsidiary of Glatton Sp. z o.o.